News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
670,705 Results
Type
Article (46008)
Company Profile (180)
Press Release (624503)
Multimedia
Podcasts (99)
Webinars (18)
Section
Business (179964)
Career Advice (2882)
Deals (33290)
Drug Delivery (129)
Drug Development (74560)
Employer Resources (195)
FDA (16005)
Job Trends (15101)
News (310901)
Policy (30043)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2828)
Academic (2)
Accelerated approval (30)
Adcomms (32)
Allergies (145)
Alliances (45412)
ALS (176)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (313)
Approvals (16285)
Artificial intelligence (552)
Autoimmune disease (155)
Automation (36)
Bankruptcy (300)
Best Places to Work (12201)
BIOSECURE Act (21)
Biosimilars (186)
Biotechnology (112)
Bladder cancer (161)
Brain cancer (57)
Breast cancer (646)
Cancer (4833)
Cardiovascular disease (402)
Career advice (2426)
Career pathing (41)
CAR-T (291)
CDC (45)
Celiac Disease (2)
Cell therapy (771)
Cervical cancer (37)
Clinical research (63853)
Collaboration (1753)
Company closure (3)
Compensation (1160)
Complete response letters (56)
COVID-19 (2703)
CRISPR (93)
C-suite (862)
Cystic fibrosis (152)
Data (6289)
Decentralized trials (1)
Denatured (35)
Depression (138)
Diabetes (492)
Diagnostics (6994)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (251)
Drug pricing (175)
Drug shortages (24)
Duchenne muscular dystrophy (218)
Earnings (73434)
Editorial (59)
Employer branding (25)
Employer resources (168)
Events (111540)
Executive appointments (1017)
FDA (19151)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1500)
Gene editing (201)
Generative AI (48)
Gene therapy (593)
GLP-1 (950)
Government (4488)
Grass and pollen (7)
Guidances (381)
Healthcare (20115)
HIV (55)
Huntington's disease (47)
IgA nephropathy (82)
Immunology and inflammation (238)
Immuno-oncology (51)
Indications (104)
Infectious disease (2968)
Inflammatory bowel disease (200)
Inflation Reduction Act (15)
Influenza (111)
Intellectual property (250)
Interviews (555)
IPO (16512)
IRA (43)
Job creations (3246)
Job search strategy (1998)
JPM (57)
Kidney cancer (17)
Labor market (86)
Layoffs (537)
Leadership (38)
Legal (6651)
Liver cancer (88)
Longevity (14)
Lung cancer (642)
Lymphoma (368)
Machine learning (43)
Management (66)
Manufacturing (785)
MASH (165)
Medical device (14492)
Medtech (14548)
Mergers & acquisitions (17934)
Metabolic disorders (1226)
Multiple sclerosis (157)
NASH (19)
Neurodegenerative disease (325)
Neuropsychiatric disorders (87)
Neuroscience (3000)
Neurotech (1)
NextGen: Class of 2026 (6952)
Non-profit (4913)
Now hiring (65)
Obesity (553)
Opinion (296)
Ovarian cancer (168)
Pain (210)
Pancreatic cancer (225)
Parkinson's disease (299)
Partnered (34)
Patents (494)
Patient recruitment (487)
Peanut (59)
People (55601)
Pharmaceutical (41)
Pharmacy benefit managers (27)
Phase 1 (19931)
Phase 2 (28221)
Phase 3 (21175)
Pipeline (5140)
Policy (267)
Postmarket research (2144)
Preclinical (8426)
Press Release (69)
Prostate cancer (241)
Psychedelics (49)
Radiopharmaceuticals (289)
Rare diseases (849)
Real estate (5457)
Recruiting (78)
Regulatory (23252)
Reports (60)
Research institute (2604)
Resumes & cover letters (463)
Rett syndrome (27)
RNA editing (15)
RSV (79)
Schizophrenia (152)
Series A (245)
Series B (189)
Service/supplier (9)
Sickle cell disease (103)
Special edition (20)
Spinal muscular atrophy (162)
Sponsored (39)
Startups (3403)
State (2)
Stomach cancer (12)
Supply chain (103)
Tariffs (76)
The Weekly (63)
Vaccines (962)
Venture capital (89)
Weight loss (357)
Women's health (80)
Worklife (22)
Date
Last 7 days (622)
Last 30 days (2179)
Last 365 days (30961)
2026 (2944)
2025 (31406)
2024 (36544)
2023 (41878)
2022 (52616)
2021 (57515)
2020 (56045)
2019 (49344)
2018 (37174)
2017 (32870)
2016 (31455)
2015 (36714)
2014 (26161)
2013 (20854)
2012 (22629)
2011 (23507)
2010 (21055)
Location
Africa (855)
Alabama (91)
Alaska (7)
Arizona (257)
Arkansas (12)
Asia (39422)
Australia (6982)
California (11416)
Canada (3298)
China (1124)
Colorado (482)
Connecticut (490)
Delaware (339)
Europe (91051)
Florida (1692)
Georgia (372)
Hawaii (4)
Idaho (62)
Illinois (900)
India (66)
Indiana (534)
Iowa (22)
Japan (424)
Kansas (126)
Kentucky (42)
Louisiana (27)
Maine (83)
Maryland (1396)
Massachusetts (8362)
Michigan (346)
Minnesota (655)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (28)
Nevada (127)
New Hampshire (86)
New Jersey (3073)
New Mexico (31)
New York (3022)
North Carolina (1532)
North Dakota (10)
Northern California (5565)
Ohio (343)
Oklahoma (22)
Oregon (42)
Pennsylvania (2294)
Puerto Rico (22)
Rhode Island (48)
South America (1176)
South Carolina (66)
South Dakota (1)
Southern California (4469)
Tennessee (174)
Texas (1779)
United States (40889)
Utah (349)
Vermont (1)
Virginia (273)
Washington D.C. (83)
Washington State (949)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
670,705 Results for "ab science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer
January 30, 2026
·
8 min read
Press Releases
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
January 8, 2026
·
11 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
·
10 min read
Press Releases
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
December 16, 2025
·
9 min read
Press Releases
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
December 23, 2025
·
8 min read
Press Releases
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
October 17, 2025
·
12 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
February 5, 2026
·
2 min read
Press Releases
AB Science announces the successful completion of a EUR 2.8 million private placement
October 17, 2025
·
11 min read
Press Releases
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
December 12, 2025
·
7 min read
1 of 67,071
Next
